A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: A huge review

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 365-376

  Gong, Chunming ^a   Hu, Xueying ^a   Gao, Yong ^a   Cao, Yunfei ^a   Gao, Feng ^a   Mo, Zengnan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

N Acetyltransferase; NAT; Phenotype; Polymorphism; Prostate cancer; Susceptibility

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; N ACETYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ETHNICITY; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ARYLAMINE N-ACETYLTRANSFERASE; GENOTYPE; HUMANS; ISOENZYMES; MALE; META-ANALYSIS AS TOPIC; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 79952248456     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-010-9423-5     Document Type: Article

References (64)

1. N Caporaso A Goldstein 1995 Cancer genes: single and susceptibility: exposing the difference Pharmacogenetics 5 2 59 63 7663529 10.1097/00008571- 199504000-00001 1:CAS:528:DyaK2MXmslynt7o%3D
2. M Blum DM Grant W McBride, et al. 1990 Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression DNA Cell Biol 9 3 193 203 2340091 10.1089/dna.1990.9.193 1:CAS:528:DyaK3cXls1Kns7w%3D
3. M Blum A Demierre DM Grant, et al. 1991 Molecular mechanism of slow acetylation of drugs and carcinogens in humans Proc Natl Acad Sci USA 88 5237 5241 1675794 10.1073/pnas.88.12.5237 1:CAS:528:DyaK3MXkvVKmtL4%3D (Pubitemid 21914719)
4. KP Vatsis KJ Martell WW Weber 1991 Diverse point mutations in the human gene for polymorphic N-acetyltransferase Proc Natl Acad Sci USA 88 6333 6337 2068113 10.1073/pnas.88.14.6333 1:CAS:528:DyaK3MXlsFahtrw%3D (Pubitemid 21914940)
5. T Ebisawa T Deguchi 1991 Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases Biochem Biophys Res Commun 177 1252 1257 1676262 10.1016/0006-291X(91)90676-X 1:CAS:528:DyaK3MXks1Gqtbo%3D
6. S Costa D Pinto A Morais, et al. 2005 Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population Prostate 64 246 252 15717312 10.1002/pros.20241 1:CAS:528:DC%2BD2MXotFSmt7c%3D (Pubitemid 40980866)
7. G Smith LA Stanley E Sim, et al. 1995 Metabolic polymorphisms and cancer susceptibility Cancer Surv 25 27 65 8718512 1:CAS:528:DyaK28XitV2mt7s%3D
8. A d'Errico E Taioli X Chen 1996 Genetic metabolic polymorphisms and the risk of cancer: a review of the literature Biomarkers 1 149 173 10.3109/13547509609079352 (Pubitemid 126710667)
9. DW Hein MA Doll AJ Fretland, et al. 2000 Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev 9 29 42 10667461 1:CAS:528:DC%2BD3cXptVOmtA%3D%3D (Pubitemid 30062907)
10. NAT2 Nomenclature [ http://louisville.edu/medschool/pharmacology/NAT.html ].
11. JA Agundez C Martinez M Olivera, et al. 1998 Expression in human prostate of drug-and carcinogen-metabolizing enzymes: association with prostate cancer risk Br J Cancer 78 1361 1367 9823980 10.1038/bjc.1998.685 1:CAS:528: DyaK1cXns1WlsLY%3D (Pubitemid 28495251)
12. T Lawson C Kolar 2002 Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens Cancer Lett 175 141 146 11741741 10.1016/S0304-3835(01)00732-7 1:CAS:528:DC%2BD3MXovF2ju78%3D (Pubitemid 34001711)
13. DW Hein MA Leff N Ishibe, et al. 2002 Association of prostate cancer with rapid N-acetyltransferase 1 (NAT110) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study Environ Mol Mutagen 40 3 161 167 12355549 10.1002/em.10103 1:CAS:528: DC%2BD38XnvFGgt7s%3D
14. C Bruhn J Brockmöller I Cascorbi, et al. 1999 Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1) Biochem Pharmacol 58 1759 1764 10571250 10.1016/S0006-2952(99)00269-5 1:CAS:528:DyaK1MXntVCgtLs%3D (Pubitemid 29505416)
15. D Labuda M Krajinovic C Richer, et al. 1999 Rapid detection of CYP1A1, CYP2D6 and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay Anal Biochem 275 84 92 10542112 10.1006/abio.1999.4293 1:CAS:528:DyaK1MXmvVyntbw%3D
16. JM Lo-Guidice D Allorge D Chevalier, et al. 2002 Molecular analysis of the N-acetyltransferase 1 gene (NAT1*) using polymerase chain reaction-restriction fragment-single strand conformation polymorphism assay Pharmacogenetics 10 293 300 10.1097/00008571-200006000-00003
17. VA Smelt HJ Mardon E Sim 1998 Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT110 and NAT24 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2 Pharmacol Toxicol 83 149 157 9820875 10.1111/j.1600-0773.1998.tb01461.x 1:CAS:528:DyaK1cXntFOmsLc%3D (Pubitemid 28487623)
18. VA Smelt A Upton J Adjaye, et al. 2000 Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos Hum Mol Genet 9 1101 1107 10767335 10.1093/hmg/9.7.1101 1:CAS:528: DC%2BD3cXivFyktLw%3D (Pubitemid 30216016)
19. T Katoh S Kaneko R Boissy, et al. 1998 A pilot study testing the association between N-acetyltransferase 1 and 2 and risk of oral squamous cell carcinoma in Japanese people Carcinogenesis 19 1803 1807 9806162 10.1093/carcin/19.10.1803 1:CAS:528:DyaK1cXntVWntbk%3D (Pubitemid 28474645)
20. A Sekine S Saito A Iida, et al. 2001 Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population J Hum Genet 46 314 319 11393533 10.1007/s100380170065 1:CAS:528:DC%2BD3MXktlektrg%3D (Pubitemid 32524628)
21. B Zhao E Lee PN Yeoh, et al. 1998 Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations Pharmacogenetics 8 299 304 9731716 10.1097/00008571-199808000-00003 1:CAS:528:DyaK1cXlvVWqtbw%3D (Pubitemid 28372323)
22. HJ Lin NM Probst-Hensch NC Hughes, et al. 1998 Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas Pharmacogenetics 8 269 281 9682272 10.1097/00008571-199806000-00009 1:CAS:528:DyaK1cXktlemtrw%3D (Pubitemid 28282883)
23. A Upton N Johnson J Sandy, et al. 2001 Arylamine N-acetyltransferases-of mice, men and microorganisms Trends Pharmacol Sci 22 140 146 11239577 10.1016/S0165-6147(00)01639-4 1:CAS:528:DC%2BD3MXhsVKksLs%3D (Pubitemid 32184288)
24. M Abe T Deguchi T Suzuki 1993 The structure and characterisation of a fourth allele of polymorphic N-acetyltransferase gene found in the Japanese population Biochem Biophys Res Commun 191 811 816 8466518 10.1006/bbrc.1993.1289 1:CAS:528:DyaK3sXitFSjs78%3D (Pubitemid 23231562)
25. D Hickman E Sim 1991 N-Acetyltransferase polymorphism: comparison of phenotype and genotype in humans Biochem Pharmacol 42 1007 1014 1872889 10.1016/0006-2952(91)90282-A 1:CAS:528:DyaK3MXlvVShs74%3D
26. T Deguchi 1992 Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver J Biol Chem 267 18140 18147 1381364 1:CAS:528:DyaK38XltVGmurY%3D
27. T Deguchi M Mashimo T Suzuki 1990 Correlations between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver J Biol Chem 265 12757 12760 2376572 1:CAS:528:DyaK3cXkvFaltbk%3D (Pubitemid 20234207)
28. E Sim D Hickman 1991 Polymorphism in human N-acetyltransferase-the case of the missing allele Trends Pharmacol Sci 12 211 213 10.1016/0165-6147(91) 90553-5
29. S Henning I Cascorbi B Münchow, et al. 1999 Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk Pharmacogenetics 9 103 111 10208649 10.1097/00008571-199902000-00014 1:CAS:528:DyaK1MXjtlyqsb4%3D (Pubitemid 29176729)
30. GA Westphal K Reich TG Schultz, et al. 2000 N-Acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy Br J Dermatol 142 1121 1127 10848734 10.1046/j.1365-2133.2000.03536.x 1:CAS:528:DC%2BD3cXltFShs78%3D (Pubitemid 30418297)
31. A Jemal T Murray E Ward, et al. 2005 Cancer statistics, 2005 CA Cancer J Clin 55 10 30 15661684 10.3322/canjclin.55.1.10 (Pubitemid 40310185)
32. Garcia M, Jemal A, Ward E, et al. Global cancer facts and figures 2007. Available from: http://www.cancer.org/downloads/STT/Global-Cancer-Facts-and- Figures-2007-rev.pdf. Accessed May 23, 2008.
33. EA Klein IM Thompson 2004 Update on chemoprevention of prostate cancer Curr Opin Urol 14 143 149 15069304 10.1097/00042307-200405000-00002 (Pubitemid 38582312)
34. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
35. P Boyle G Severi GG Giles 2003 The epidemiology of prostate cancer Urol Clin North Am 30 209 217 12735498 10.1016/S0094-0143(02)00181-7 (Pubitemid 36520595)
36. M Yin S Bastacky U Chandran, et al. 2008 Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors J Urol 179 892 895 18207193 10.1016/j.juro.2007.10.057
37. CY Wang M Debiec-Rychter HA Schut, et al. 1999 N-Acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium Carcinogenesis 20 1591 1595 10426812 10.1093/carcin/20.8.1591 1:CAS:528:DyaK1MXltlKnsro%3D (Pubitemid 29385450)
38. DW Hein DM Grant E Sim 2000 Update on consensus arylamine N-acetyltransferase gene nomenclature Pharmacogenetics 10 4 291 292 10862519 10.1097/00008571-200006000-00002 1:CAS:528:DC%2BD3cXksFSqsbo%3D (Pubitemid 30345176)
39. JL Beebe-Dimmer AM Levin AM Ray, et al. 2008 Chromosome 8q24 markers: risk of early-onset and familial prostate cancer Int J Cancer 122 12 2876 2879 18360876 10.1002/ijc.23471 1:CAS:528:DC%2BD1cXht1eku7jO (Pubitemid 351631393)
40. ML Slattery SL Edwards W Samowitz, et al. 2000 Associations between family history of cancer and genes coding for metabolizing enzymes (United States) Cancer Causes Control 11 9 799 803 11075868 10.1023/A:1008912317909 1:STN:280:DC%2BD3M3osVeruw%3D%3D
41. JA Agúndez 2008 Polymorphisms of human N-acetyltransferases and cancer risk Curr Drug Metab 9 6 520 531 18680472 10.2174/138920008784892083 (Pubitemid 352025183)
42. K Dalhoff K Buus Jensen H Enghusen Poulsen 2005 Cancer and molecular biomarkers of phase 2 Methods Enzymol 400 618 627 16399374 10.1016/S0076- 6879(05)00035-2 1:CAS:528:DC%2BD28XoslCjur0%3D (Pubitemid 43052444)
43. E Reszka W Wasowicz 2002 Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system Minirev Neoplasma 49 4 209 216 1:CAS:528:DC%2BD38XotlGgtLY%3D
44. Y Kinoshita A Singh PM Rovito Jr, et al. 2004 Double primary cancers of the prostate and bladder: a literature review Clin Prostate Cancer 3 2 83 86 15479490 (Pubitemid 39403225)
45. S Hooker C Bonilla F Akereyeni, et al. 2008 NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans Prostate Cancer Prostatic Dis 11 4 349 356 18026184 10.1038/sj.pcan.4501027 1:CAS:528:DC%2BD1cXhtlCktrrO
46. PM Rovito Jr PD Morse K Spinek, et al. 2005 Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancer Prostate Cancer Prostatic Dis 8 1 69 74 15685255 10.1038/sj.pcan.4500780 1:CAS:528:DC%2BD2MXisVShsrs%3D
47. CY Wang RF Jones M Debiec-Rychter, et al. 2002 Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study Anticancer Res 22 6B 3529 3535 12552951 1:CAS:528:DC%2BD3sXhtFGmsbo%3D (Pubitemid 36132824)
48. M Wadelius JL Autrup MJ Stubbins, et al. 1999 Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer Pharmacogenetics 9 3 333 340 10471065 10.1097/00008571-199906000-00008 1:CAS:528:DyaK1MXlsFGls78%3D (Pubitemid 29376377)
49. DS Srivastava RD Mittal 2005 Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population BMC Urol 5 12 16083506 10.1186/1471-2490-5-12 (Pubitemid 41215513)
50. JP Gao YD Huang GZ Yang, et al. 2003 Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer Zhonghua Nan Ke Xue 9 1 32 35 12680328 1:CAS:528:DC%2BD2cXitFGjtQ%3D%3D
51. T Hamasaki H Inatomi T Katoh, et al. 2003 N-Acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men Int J Urol 10 3 167 173 12622714 10.1046/j.1442-2042.2003.00586.x 1:CAS:528: DC%2BD3sXjsl2rsL4%3D (Pubitemid 36470028)
52. K Fukutome M Watanabe T Shiraishi, et al. 1999 N-Acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development Cancer Lett 136 1 83 87 10211944 10.1016/S0304-3835(98)00311-5 1:CAS:528: DyaK1MXps1KitA%3D%3D (Pubitemid 29145218)
53. T Iguchi S Sugita CY Wang, et al. 2009 MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status In Vivo 23 1 7 12 19368118 1:CAS:528:DC%2BD1MXktlKjsLo%3D
54. M Blettner W Sauerbrei B Schlehofer, et al. 1999 Traditional reviews, meta-analyses and pooled analyses in epidemiology Int J Epidemiol 28 1 9 10195657 10.1093/ije/28.1.1 1:STN:280:DyaK1M3htVSgsA%3D%3D (Pubitemid 29086203)
55. SL Slager KE Zarfas WM Brown, et al. 2006 Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project Prostate 66 173 179 16173044 10.1002/pros.20332 1:CAS:528:DC%2BD28Xhs1KmsL0%3D (Pubitemid 43191238)
56. J Xu EM Gillanders SD Isaacs, et al. 2003 Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families Prostate 57 320 325 14601028 10.1002/pros.10306 1:CAS:528: DC%2BD2cXpslWr (Pubitemid 37487077)
57. F Wiklund EM Gillanders JA Albertus, et al. 2003 Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3 Prostate 57 290 297 14601025 10.1002/pros.10303 1:CAS:528:DC%2BD2cXpslWm (Pubitemid 37487074)
58. S Edwards J Meitz R Eles, et al. 2003 Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium Prostate 57 270 279 14601023 10.1002/pros.10301 (Pubitemid 37487072)
59. JL Stanford LM Fitzgerald SK McDonnell, et al. 2009 Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage Hum Mol Genet 18 10 1839 1848 19251732 10.1093/hmg/ddp100 1:CAS:528:DC%2BD1MXltV2gs7k%3D
60. M Yeager N Orr RB Hayes, et al. 2007 Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 Nat Genet 39 645 649 17401363 10.1038/ng2022 1:CAS:528:DC%2BD2sXksFersb4%3D (Pubitemid 46676108)
61. J Gudmundsson P Sulem A Manolescu, et al. 2007 Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Nat Genet 39 631 637 17401366 10.1038/ng1999 1:CAS:528:DC%2BD2sXksFersL0%3D (Pubitemid 46676102)
62. RA Eeles J Kote-Jarai GG Giles, et al. 2008 Identification of multiple novel prostate cancer susceptibility loci by a genome-wide association study Nat Genet 40 316 321 18264097 10.1038/ng.90 1:CAS:528:DC%2BD1cXisVKht74%3D (Pubitemid 351311772)
63. G Thomas KB Jacobs M Yeager, et al. 2008 Multiple loci identified in a genome-wide association study of prostate cancer Nat Genet 40 310 315 18264096 10.1038/ng.91 1:CAS:528:DC%2BD1cXisVKht78%3D (Pubitemid 351311773)
64. Ries L, Melbert D, Drapcho M, et al. SEER cancer statistics review (based on November 2007 SEER data submission, posted to the SEER Web site, 2008). Available from: http://seer.cancer.gov/csr/1975-2005/. Accessed 30 May, 2008.